Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 5, 2010, Pages 605-613

  Hersh, Craig P ^a   Pillai, Sreekumar G ^b,p   Zhu, Guohua ^b   Lomas, David A ^c   Bakke, Per ^d   Gulsvik, Amund ^d   DeMeo, Dawn L ^a   Klanderman, Barbara J ^a   Lazarus, Ross ^a   Litonjua, Augusto A ^a   Sparrow, David ^e   Reilly, John J ^f   Agusti, Alvar ^g   Calverley, Peter M A ^h   Donner, Claudio F ⁱ   Levy, Robert D ^j   Make, Barry J ^k   Paré, Peter D ^j   Rennard, Stephen I ^l   Vestbo, Jørgen ^m   Wouters, Emiel F M ⁿ   Scholand, Mary Beth ^o   Coon, Hilary ^o   Hoidal, John ^o   Silverman, Edwin K ^a   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF BERGEN   (Norway)

^e BOSTON UNIVERSITY   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^h UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁱ IRCCS   (Italy)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k DEPARTMENT OF MEDICINE   (United States)

^l UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^m HVIDOVRE HOSPITAL   (Denmark)

ⁿ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^o UNIVERSITY OF UTAH   (United States)

^p HOFFMANN LA ROCHE INC   (United States)

more..

Author keywords

Emphysema; Genetic linkage; Metaanalysis; Single nucleotide polymorphism

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 2Q; CHROMOSOME IDENTIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FAMILY; FEMALE; FOLLOW UP; GENE MAPPING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME 2; CHROMOSOME MAP; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; ONSET AGE; SMOKING;

AMYLOID PRECURSOR PROTEIN; CELL SURFACE RECEPTOR; HELICASE; PROTEASE NEXINS; XRCC5 PROTEIN, HUMAN;

AGE OF ONSET; AGED; AMYLOID BETA-PROTEIN PRECURSOR; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 2; DNA HELICASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CELL SURFACE; SMOKING;

EID: 77957707296     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200910-1586OC     Document Type: Article

References (42)

1. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S, Depner M, von Berg A, Bufe A, Rietschel E, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007;448:470-473.
2. Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008;358:1682-1691.
3. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009;5:e1000421.
4. Topol EJ, Murray SS, Frazer KA. The genomics gold rush. JAMA 2007;298:218-221.
5. Silverman EK, Palmer LJ, Mosley JD, Barth M, Senter JM, Brown A, Drazen JM, Kwiatkowski DJ, Chapman HA, Campbell EJ, et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am J Hum Genet 2002;70:1229-1239. (Pubitemid 34450572)
6. DeMeo DL, Celedon JC, Lange C, Reilly JJ, Chapman HA, Sylvia JS, Speizer FE, Weiss ST, Silverman EK. Genome-wide linkage of forced mid-expiratory flow in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:1294-1301.
7. Demeo DL, Mariani TJ, Lange C, Srisuma S, Litonjua AA, Celedon JC, Lake SL, Reilly JJ, Chapman HA, Mecham BH, et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease. Am J Hum Genet 2006;78:253-264. (Pubitemid 43157565)
8. Malhotra A, Peiffer AP, Ryujin DT, Elsner T, Kanner RE, Leppert MF, Hasstedt SJ. Further evidence for the role of genes on chromosome 2 and chromosome 5 in the inheritance of pulmonary function. Am J Respir Crit Care Med 2003;168:556-561.
9. Postma DS, Meyers DA, Jongepier H, Howard TD, Koppelman GH, Bleecker ER. Genomewide screen for pulmonary function in 200 families ascertained for asthma. Am J Respir Crit Care Med 2005;172:446-452.
10. Hersh CP, Pillai SG, Zhu G, Lomas DA, Bakke P, Gulsvik A, DeMeo DL, Litonjua AA, Reilly JJ, Silverman EK, et al. Multi-study fine mapping of a COPD susceptibility locus on chromosome 2q [abstract]. Am J Respir Crit Care Med 2008;177:A907.
11. Hersh CP, Demeo DL, Lange C, Litonjua AA, Reilly JJ, Kwiatkowski D, Laird N, Sylvia JS, Sparrow D, Speizer FE, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005;33:71-78.
12. Zhu G, Warren L, Aponte J, Gulsvik A, Bakke P, Anderson WH, Lomas DA, Silverman EK, Pillai SG. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med 2007;176:167-173.
13. Patel BD, Coxson HO, Pillai SG, Agusti AG, Calverley PM, Donner CF, Make BJ, Muller NL, Rennard SI, Vestbo J, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:500-505.
14. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
15. Bell B, Rose CL, Damon H. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev 1972;3:5-17.
16. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-120. (Pubitemid 38085242)
17. International HapMap Consortium. The International HapMap Project. Nature 2003;426:789-796.
18. Silverman EK, Lake SL, Lomas DA, Rennard SI, Pare PD, Calverley PM, Vestbo J, Wouters EF, Agusti AG, Donner CF, et al. Linkage analysis of quantitative emphysema phenotypes in chronic obstructive pulmonary disease [abstract]. Proc Am Thorac Soc 2006;3:A620.
19. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
20. Poisson LM, Rybicki BA, Coon SW, Barnholtz-Sloan JS, Chase GA. Susceptibility scoring in family-based association testing. BMC Genet 2003;4:S49.
21. Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. PBAT: tools for family-based association studies. Am J Hum Genet 2004;74:367-369.
22. Fisher RA. Statistical methods for research workers. London: Oliver and Boyd, Ltd.; 1925.
23. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008;40:161-169.
24. Kraft P. Curses-winner's and otherwise-in genetic epidemiology. Epidemiology 2008;19:649-651; discussion 657-658.
25. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497-1505.
26. Nussenzweig A, Chen C, da Costa Soares V, Sanchez M, Sokol K, Nussenzweig MC, Li GC. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 1996;382:551-555.
27. Tuder RM. Aging and cigarette smoke: fueling the fire. Am J Respir Crit Care Med 2006;174:490-491.
28. Karrasch S, Holz O, Jorres RA. Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med 2008;102:1215-1230.
29. Suga T, Kurabayashi M, Sando Y, Ohyama Y, Maeno T, Maeno Y, Aizawa H, Matsumura Y, Kuwaki T, Kuro OM, et al. Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. Am J Respir Cell Mol Biol 2000;22:26-33.
30. Vogel H, Lim DS, Karsenty G, Finegold M, Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci USA 1999;96:10770-10775.
31. Yaneva M, Arnett FC. Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol 1989;76:366-372. (Pubitemid 19172264)
32. Agusti A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax 2003;58:832-834.
33. Taraseviciene-Stewart L, Burns N, Kraskauskas D, Nicolls MR, Tuder RM, Voelkel NF. Mechanisms of autoimmune emphysema. Proc Am Thorac Soc 2006;3:486-487.
34. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-569.
35. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360:2445-2454.
36. Hoffman EA. Quantitative image analysis in predicting outcomes in NETT. American Thoracic Society International Conference. 2004. Orlando, FL.
37. Maeda Y, Hunter TC, Loudy DE, Dave V, Schreiber V, Whitsett JA. PARP-2 interacts with TTF-1 and regulates expression of surfactant protein-B. J Biol Chem 2006;281:9600-9606.
38. Guo X, Lin HM, Lin Z, Montano M, Sansores R, Wang G, DiAngelo S, Pardo A, Selman M, Floros J. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001;18:482-490.
39. Seifart C, Plagens A, Brodje D, Muller B, von Wichert P, Floros J. Surfactant protein B intron 4 variation in German patients with COPD and acute respiratory failure. Dis Markers 2002;18:129-136.
40. Chappell S, Daly L, Morgan K, Baranes TG, Roca J, Rabinovich R, Millar A, Donnelly SC, Keatings V, MacNee W, et al. The SERPINE2 gene and chronic obstructive pulmonary disease. Am J Hum Genet 2006;79:184-186, author reply 186-187.
41. Anderson CA, Pettersson FH, Barrett JC, Zhuang JJ, Ragoussis J, Cardon LR, Morris AP. Evaluating the effects of imputation on the power, coverage, and cost efficiency of genome-wide SNP platforms. Am J Hum Genet 2008;83:112-119.
42. Huang L, Wang C, Rosenberg NA. The relationship between imputation error and statistical power in genetic association studies in diverse populations. Am J Hum Genet 2009;85:692-698.